Cardioversion in atrial fibrillation is associated with an increased thromboembolic risk. The current recommendation is therapeutic anticoagulation with warfarin for at least 3 weeks before and 4 weeks after cardioversion; this recommendation is based on small nonrandomized observational and retrospective studies. Dabigatran is a novel oral direct thrombin inhibitor with rapid onset of action (peak levels in 2 hours) and a half-life of 12 to 17 hours. It was recently approved for stroke prevention in atrial fibrillation. The phase 3 Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial demonstrated that dabigatran 150 mg twice daily was superior and dabigatran 110 mg twice daily was noninferior to warfarin for stroke prevention in atrial fibrillation. With 18 113 patients, RE-LY is the largest atrial fibrillation trial and provided a unique opportunity to evaluate the postcardioversion thromboembolic risk in patients who underwent cardioversion. A total of 1983 cardioversions were performed during the RE-LY study: 647, 672, and 664 in the dabigatran 110 mg, dabigatran 150 mg, and warfarin groups, respectively. The frequencies of stroke and major bleeding within 30 days of cardioversion on the 2 doses of dabigatran were low and comparable to those on warfarin, with or without transesophageal echocardiography guidance. This posthoc analysis is the largest cardioversion experience to date and was the first to evaluate a novel anticoagulant in this setting. It also confirmed the efficacy and safety of warfarin in cardioversion in a large cohort of warfarintreated patients. The 2 drugs are comparable, and dabigatran is a reasonable alternative to warfarin in patients requiring cardioversion. See p 131.
Mechanisms of Atrial Tachyarrhythmias Associated With Coronary Artery Occlusion in a Chronic Canine Model
Coronary artery disease is an important risk factor for atrial fibrillation (AF), but the underlying mechanisms have not been explored extensively. In this study, we considered the hypothesis that chronic obstructive coronary artery disease can create a substrate for AF initiation and maintenance by altering atrial properties. In a chronic dog model, we ligated a small coronary artery that provides blood flow only to a portion of the right atrial free wall. After coronary artery ligation, dogs showed increased occurrence of spontaneous atrial ectopy and atrial tachyarrhythmias, along with a substrate for AF maintenance. Cellular studies showed that spontaneous ectopy was related to triggered activity caused by Ca 2ϩ -handling abnormalities, including enhanced Na ϩ -Ca 2ϩ exchange current and spontaneous quantal Ca 2ϩ releases (sparks) occurring during adrenergically driven Ca 2ϩ loading. AF maintenance was related to stable rotors located in the border zone of the atrial infarction resulting from coronary artery occlusion. Local conduction abnormalities in the heterogeneous border zone of the infarction provided the substrate for reentry. These results show that chronic occlusive disease of coronary arteries supplying atrial tissue produces atrial abnormalities that provide both triggers for AF initiation and a substrate for AF maintenance. They indicate a potential mechanism for the observed association between coronary artery disease and AF. These mechanistic concepts may be useful for understanding AF pathophysiology and developing new mechanism-based approaches to patient-specific therapeutics. See p 137.
Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting
Use of endoscopic saphenous vein harvesting has developed into a routine surgical approach at many cardiothoracic surgical centers, although its association with long-term morbidity and mortality has recently been called into question. We undertook a retrospective analysis of our experience in northern New England during a time period in which both open and endoscopic techniques were being performed. From 2001 to 2004, 8542 patients underwent isolated coronary artery bypass grafting procedures, 52.5% with endoscopic vein harvesting. Surgical discretion dictated the vein harvest approach. The main outcomes were death and repeat revascularization within 4 years of the index admission. The use of endoscopic vein harvesting increased from 34% in 2001 to 75% in 2004. In general, patients undergoing endoscopic vein harvesting had greater disease burden. Endoscopic vein harvesting was associated with an increased adjusted risk of bleeding requiring a return to the operating room (2.4 versus 1.7; Pϭ0.03) but a decreased risk of leg wound infections (0.2 versus 1.1; PϽ0.001). Use of endoscopic vein harvesting was associated with a significant reduction in long-term mortality (adjusted hazard ratio, 0.74) but a nonsignificant increased risk of repeat revascularization (adjusted hazard ratio, 1.29). Similar results were obtained in propensity-matched analysis. These findings suggest that endoscopic vein harvesting is a safe and viable technique for obtaining saphenous vein conduit for coronary artery bypass grafting surgery. Additional studies are warranted to improve our understanding of the mechanism by which endoscopic vein harvesting influences long-term outcomes, as well as how clinical teams can maximize the utility of this technique. See p 147.
Long-Term Outcome and Impact of Surgery on Adults With Coronary Arteries Originating From the Opposite Coronary Cusp
The presence of an anomalous coronary artery arising from the opposite sinus of Valsalva may increase the risk of sudden death risk in children and young adults, but its impact and management in the adult are poorly defined. The recently published American College of Cardiology/American Heart Association Guidelines for the Management of Adults With Congenital Heart Disease suggest an important role for surgical revascularization when such a lesion is discovered, but the recommendation is based on few clinical data. We examined a large single institution's experience over a 40-year period to further assess the importance of these lesions and the impact of surgery. We identified 301 patients with anomalous coronary artery arising from the opposite sinus of Valsalva, with anomalous right coronary arteries being found more commonly than anomalous left coronaries (Ϸ4:1). In 54 patients, the lesion passed between the aorta and the pulmonary artery (interarterial course), anatomy that has been believed to place the patient at substantially higher risk. Surgery was more commonly performed in patients with anomalous left coronary arteries, interarterial course, positive stress testing, and in the presence of concurrent coronary disease and appeared to become the highly favored strategy over the past decade. Among the patients with interarterial course, 28 underwent surgical repair with no perioperative deaths but with long-term survival similar to that of the unrepaired cohort. Quality of life was not formally assessed in this study. Our results suggest that anomalous coronary artery arising from the opposite sinus of Valsalva with 
Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) Study
The endothelium plays a prominent role in vascular homeostasis and in health inhibits atherosclerosis formation and its complications. Conduit vessel function can be readily measured noninvasively by assessing flow-mediated dilation after a hyperemic stimulus. Blood flow at the tissue level determines organ viability and is controlled mainly at the microvascular level. Thus, there has been recent interest in measures of microvascular function and its clinical relevance. In the present study, we demonstrated in a large, longterm, prospective cohort of healthy men a number of important and novel findings. First, unlike some previous studies, flow-mediated dilation was not associated with vascular events. However, the hyperemic stimulus was an independent risk marker after Framingham risk score was considered. Second, carotid intima-media thickness was also associated with events, and this association remained after correction for Framingham risk and the hyperemic stimulus. This suggests that measures of both structure and microvascular function are risk predictors for adverse outcomes and provide synergistic information. The present study adds further evidence to the literature that these end points are surrogate measures of atherosclerosis outcomes and can be used in clinical research. Finally, because hyperemic velocity is a readily measured outcome variable, it has the potential to be incorporated into clinical care if further studies support our reported association. This would be most applicable to intermediate-risk individuals in whom additional testing has been advocated for clinical decision making. See p 163.
Glucose-Insulin-Potassium Reduces the Incidence of Low Cardiac Output Episodes After Aortic Valve Replacement for Aortic Stenosis in Patients With Left Ventricular Hypertrophy: Results From the Hypertrophy, Insulin, Glucose, and Electrolytes (HINGE) Trial
Although advances in surgical and myocardial preservation techniques have substantially reduced the operative risks associated with cardiac surgery, aortic valve replacement surgery is increasingly being performed in elderly high-risk patients who are at high risk of hemodynamic insults such as low cardiac output syndrome. In this single-center, randomized, double-blind, placebo-controlled trial in patients undergoing aortic valve replacement, glucose-insulinpotassium improved the hemodynamic status of treated patients compared with those on placebo. The mechanisms contributing to this beneficial effect of glucose-insulin-potassium are complex and include metabolic enhancement. We demonstrate for the first time in humans that glucose-insulin-potassium augments myocardial signalling by increasing protein O-linked ␤-N-acetylglucosamination of selective proteins and Akt/5Ј-AMP-activated protein kinase phosphorylation. Although requiring replication, this study provides a rationale for the instigation of glucose-insulin-potassium during cardiac surgery and mandates a more detailed assessment of the link between O-linked ␤-N-acetylglucosamination and cardioprotection during ischemia/reperfusion in humans. See p 170.
Valve Configuration Determines Long-Term Results After Repair of the Bicuspid Aortic Valve
Valve replacement has been a reliable therapy for bicuspid aortic valve dysfunction for decades. To minimize valve-related complications, repair techniques have been developed in the last 2 decades. Repair of the bicuspid valve has been less challenging geometrically because only 1 coaptation line has to be corrected. Different publications, however, have given a puzzling view of the functional results of reconstruction with generally excellent early results and a worrisome rate of midterm failures. In the present study, we have found answers and new questions. The positive message is that reconstruction of bicuspid aortic valves is worthwhile for the low prevalence of valve-related complications. Repair works well with excellent durability in certain anatomical situations but should be avoided, at least with current reconstructive techniques, in others. A strong influence of anatomical characteristics on long-term durability of repair was found, with commissural orientation and degree of annular dilatation as the 2 most important predictors. Repair also had to normalize cusp configuration to achieve a good long-term result. On the other hand, the findings also emphasize the fact that bicuspid anatomy is not constant but rather includes a wide spectrum of anatomic variations. It is unclear whether annular dilatation is determined by anatomy or the duration of regurgitation. Thus, we need to define whether it can be neutralized by earlier repair. Surgeons will have to develop new strategies to ultimately allow durable reconstructive surgery in a larger proportion of patients with this anomaly. See p 178.
Depot-Specific Differences and Insufficient Subcutaneous Adipose Tissue Angiogenesis in Human Obesity
One of the most important functions of adipose tissue is to provide sufficient storage for excess calories in the form of triglycerides. Insufficient storage leads to increased circulating free fatty acids and ectopic lipid deposition, factors that are thought to result in insulin resistance and subsequently lead to type 2 diabetes mellitus. The storage capacity of adipose tissue is determined by the combination of adipocyte hypertrophy and hyperplasia, which gives rise to expanded tissue mass. However, in humans the expansion of adipose tissue in response to excess caloric intake is not always uniform. In some individuals, a disproportionate expansion of visceral relative to subcutaneous adipose tissue occurs. This manifests as an increased waist-to-hip ratio and is associated with elevated risk of metabolic disease. The mechanisms that support or limit the expandability of specific adipose tissue depots are not known. However, like the growth of any tissue, adipose expansion must require an adequate vascular supply. Thus, it is possible that adipose tissue angiogenesis might play a role in determining adipose tissue expandability. In this article, we describe an approach to investigate adipose tissue angiogenesis, in which angiogenic capacity is measured ex vivo and compared with tissue capillary density. With this approach, we conclude that different adipose tissue depots display differences in angiogenic capacity and that angiogenic capacity correlates with the metabolic manifestations of obesity, such as insulin resistance. More work to investigate adipose tissue angiogenic potential within the spectrum of lean to obese individuals must be done to define the relationship between depot-specific angiogenesis and metabolic disease. See p 186.
